Dividend Increases for the Week Ending August 1
August 4, 2014
Below we provide a list of firms that raised their dividends during the week ending August 1. The dividend reports of covered firms on this list will be updated shortly with the new information. To access the dividend reports please use the ‘Symbol’ search box in the website header. Firms Raising Their Dividends This Week Acme United (ACU): now $0.09 per share quarterly dividend, was $0.08. Alliance Resource Partners (ARLP): now $0.625 per share quarterly distribution, was $0.611. CBOE (CBOE): now $0.21 per share quarterly dividend, was $0.18. CorEnergy (CORR): now $0.13 per share quarterly dividend, was $0.129. Crane (CR): now $0.33 share quarterly dividend, was $0.30. Healthcare Trust of America (HTA): now $0.145 per share quarterly dividend, was $0.14375. Host
Valuentum’s August Edition of Its Dividend Growth Newsletter!
August 2, 2014
Please download the August edition of the Dividend Growth Newsletter .
Procter & Gamble Wraps Up a Strong Fiscal Year 2014
August 1, 2014
Procter & Gamble (PG) reported strong fiscal fourth-quarter results Friday. The April-June quarter revealed organic sales expansion of 2% thanks to strong pricing expansion and core earnings-per-share growth of 20%, to $0.95. Excluding the negative impact of foreign exchange, currency-neutral core earnings per share increased 25%. We continue to like the pricing power of Procter & Gamble’s brands, and the pace of earnings growth was fantastic during the last quarter of its fiscal year. Management continues to deliver on its top and bottom-line commitments. P&G’s brands include Tide, Ariel, Gillette, Venus, Bounty, Charmin, Pantene, Olay, Pampers, Crest, Oral-B, Duracell, and Vicks. These brands aren’t going away anytime soon, in our view. Though management indicated that it will shed some lower-margin brands,
Markets Collapse: Economic Sanctions on Russia, Argentina Defaults…Again
August 1, 2014
Dow Jones falls over 300 points Thursday on Argentina default and economic sanctions on Russia. The very idea that we don’t know which hedge funds will be hurt by recent global economic activity, how leveraged these hedge funds are to global currencies and equities, and whether Russian president Vladimir Putin will respond in kind to economic sanctions means conservative investors are taking money off the table. Is it finally time to lock in profits after one of the best stock-market runs of all time from the March 2009 lows? First, the EU and US impose economic sanctions on Russia. Next, Argentina defaults on its debt for the second time in 12 years, bringing back memories of the infamous collapse of
Union Pacific Still on Track
July 31, 2014
Union Pacific (UNP) reported solid second-quarter results July 24 and raised its quarterly dividend 10% today. The headline to the railroad’s second-quarter results said it best: All-Time Quarterly Records. The firm’s operating revenue advanced 10%, operating income increased 17%, and diluted earnings per share leapt 21%, to $1.43, all over the same period a year ago. Union Pacific’s operating ratio—the inverse of the operating margin in railroad speak—advanced 2.2 points, to 63.5%, as efficiency improvements and price increases drive the higher levels of profitability. Ongoing improvement to the firm’s operating ratio is core to our fundamental thesis on the company. Railroads simply have fantastic business models, and we think the group is on the cusp of a multi-year cycle of
Teva: Progressing As Expected; US Generic Revenue Reveals Strength
July 31, 2014
On Thursday, Teva (TEVA) reported in-line second-quarter results. For followers of the Best Ideas portfolio, the firm had a rough start shortly after it was added to the portfolio, but recent performance has put holders well into the black. For those interested in the background on the investment thesis on shares of Teva, please have a read of ‘Teva Pharma: Underpriced and Misunderstood.’ Teva’s revenue during the second-quarter nudged 3% higher, while non-GAAP operating income jumped 8%. Non-GAAP diluted earnings per share of $1.23 came in 3% higher than the same period a year ago. The company delivered organic growth in revenue and all profit lines over the comparable quarter last year. Though the results were solid, the thesis on
PPL Beats Expectations and Raises Guidance
July 31, 2014
We recently wrote up a relatively extensive piece on ‘Utilities Are Safe Income Vehicles…Most of the Time,” that we think is worth reading before diving into PPL’s (PPL) solid second quarter results, released Thursday. For many income investors, dividends aren’t everything, they are the only thing, and we understand how important it is for us to focus on sustainable dividend growth in any idea that we present within the Dividend Growth portfolio, a collection of equities that we think will continue raising their dividends long into the future. We think PPL is one such company. The company’s second-quarter and first-half earnings from ongoing operations increased 15% over the corresponding periods from 2013. Management couldn’t have said it better: “Strong performance
Big Pharma Round Up
July 30, 2014
Though much has been made about the patent cliff—shorthand for the expiration of the patents of a large number of drugs over a short period of time—we continue to believe that pipelines across much of the pharmaceutical space are flush with new drugs and therapies. Readers may have an individual favorite or two (or three) within the space (and there’s nothing wrong with that), but we think one of the best ways for investors to play the strong pipelines across the healthcare sector—and ongoing consolidation—is through the Health Care Select SPDR ETF (XLV), a holding in the Best Ideas portfolio. The ETF boasts Johnson & Johnson (JNJ), Pfizer (PFE), Merck (MRK), Gilead Sciences (GILD), and AbbVie (ABBV) as its top
Buffalo Wild Wings’ Pizza Rev Is a Hidden Gem
July 30, 2014
Buffalo Wild Wings (BWLD) has been one of the best performing restaurants during the past few years. We credit the restaurant’s strong multi-year run to a solid concept, continued strong same-store sales expansion, and excellent cost containment (via serving size innovation). The restaurant’s second-quarter results, released Tuesday, were solid. Total revenue increased 20% during the quarter, while same-store sales increased 7.7% at company-owned restaurants and 6.5% at franchised restaurants. Net earnings increased nearly 44% to $23.7 million from $16.5 million, and earnings per diluted share increased at a similar pace, to $1.25. The company benefited from lower costs thanks in part to a decrease in the price-per-pound for traditional chicken wings. From the same period in 2013, the company had
Quick Tip: Keep Things in Perspective
July 28, 2014
Best Ideas portfolio holdings Visa (V) and Precision Castparts (PCP) recently reported relatively disappointing calendar second-quarter results (here and here). Share prices of both portfolio constituents sold off a few percentage points following their respective earnings releases. Though growing more concerned when share prices drop is natural (and perhaps rightly so in some cases), one of the most effective approaches to staving off behavioral and psychological pitfalls (e.g. selling at the bottom, truncating gains, etc.) is to keep things in perspective. In situations where a company’s stock has doubled or tripled, for example, a 5%-10% pullback should be viewed as “normal” trading activity, resulting from the concept of ‘profit-taking,’ or when some shareholders take some of their profits off the table
